Registered number
12304352
SNS Dermatology and Skin Cancer Services Limited
Filleted Accounts
31 March 2025
SNS Dermatology and Skin Cancer Services Limited
Registered number: 12304352
Balance Sheet
as at 31 March 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 16,517 -
Current assets
Debtors 4 200 200
Cash at bank and in hand 16,939 34,133
17,139 34,333
Creditors: amounts falling due within one year 5 (2,478) (3,184)
Net current assets 14,661 31,149
Net assets 31,178 31,149
Capital and reserves
Called up share capital 100 100
Profit and loss account 31,078 31,049
Shareholders' funds 31,178 31,149
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Syed Nasir Shah
Director
Approved by the board on 27 June 2025
SNS Dermatology and Skin Cancer Services Limited
Notes to the Accounts
for the year ended 31 March 2025
1 Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts. Turnover includes revenue earned from the rendering of services.Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Fixtures, fittings, tools and equipment 20%RBM
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 2 2
3 Tangible fixed assets
Plant and machinery etc Motor vehicles Total
£ £ £
Cost
Additions 1,896 15,000 16,896
At 31 March 2025 1,896 15,000 16,896
Depreciation
Charge for the year 379 - 379
At 31 March 2025 379 - 379
Net book value
At 31 March 2025 1,517 15,000 16,517
4 Debtors 2025 2024
£ £
Other debtors 200 200
5 Creditors: amounts falling due within one year 2025 2024
£ £
Director's account 2,295 606
Taxation and social security costs - 2,410
Other creditors 183 168
2,478 3,184
6 Other information
SNS Dermatology and Skin Cancer Services Limited is a private company limited by shares and incorporated in England. Its registered office is:
31 Ebbisham Drive
Norwich
Norfolk
NR4 6HQ
SNS Dermatology and Skin Cancer Services Limited 12304352 false 2024-04-01 2025-03-31 2025-03-31 VT Final Accounts April 2024 Syed Nasir Shah No description of principal activity 12304352 2023-04-01 2024-03-31 12304352 core:WithinOneYear 2024-03-31 12304352 core:ShareCapital 2024-03-31 12304352 core:RetainedEarningsAccumulatedLosses 2024-03-31 12304352 2024-04-01 2025-03-31 12304352 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12304352 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12304352 bus:Director40 2024-04-01 2025-03-31 12304352 1 2024-04-01 2025-03-31 12304352 2 2024-04-01 2025-03-31 12304352 core:PlantMachinery 2024-04-01 2025-03-31 12304352 core:Vehicles 2024-04-01 2025-03-31 12304352 countries:England 2024-04-01 2025-03-31 12304352 bus:FRS102 2024-04-01 2025-03-31 12304352 bus:FilletedAccounts 2024-04-01 2025-03-31 12304352 2025-03-31 12304352 core:WithinOneYear 2025-03-31 12304352 core:ShareCapital 2025-03-31 12304352 core:RetainedEarningsAccumulatedLosses 2025-03-31 12304352 core:PlantMachinery 2025-03-31 12304352 core:Vehicles 2025-03-31 12304352 2024-03-31 iso4217:GBP xbrli:pure